Mar. 3, 2026
Cactus Reports Strong Q4 2025 Earnings
Pressure Control segment performs well, Spoolable Technologies maintains profitability despite seasonal decline
Mar. 2, 2026
Pool Corporation to Participate in Investor Conference
Senior VP and CFO Melanie M. Hart to attend Loop Capital Markets 2026 event
Mar. 2, 2026
Enovis Reports Strong Q4 and Full-Year 2025 Results
Medical technology company highlights organic growth, margin expansion, and free cash flow improvements.
Feb. 28, 2026
Enovis Reports Strong 2025 Performance, Outlines 2026 Outlook
Medical technology company sees continued organic growth, margin expansion, and improved cash flow conversion.
Feb. 28, 2026
Ecovyst Reports Strong Q4, Focuses on Virgin and Regenerated Sulfuric Acid
Company completes divestiture of Advanced Materials & Catalysts segment, pays down debt, and plans capital investments in Gulf Coast region
Feb. 28, 2026
Law Firm Launches Investigation into Dream Finders Homes
Kahn Swick & Foti, LLC looking into potential breaches of fiduciary duty by officers and directors
Feb. 27, 2026
Calumet Reports Strong Q4 and Full-Year 2025 Results
Specialty Products and Solutions segment posts record production and margins, while Montana Renewables focuses on SAF expansion and cost improvements
Feb. 25, 2026
Pool Corp Misses Q4 Earnings Estimates
Specialty retailer reports lower-than-expected profits despite solid revenue
Feb. 25, 2026
Corcept Therapeutics Faces Securities Fraud Class Action After FDA Approval Issues
Investors may contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC for more information
Feb. 23, 2026
Kahn Swick & Foti Launches Investigation into e.l.f. Beauty
Law firm probes allegations of overstated revenue and concealed inventory challenges
Feb. 23, 2026
Kyndryl Shareholders Alerted to Lead Plaintiff Deadline in Class Action Lawsuit
ClaimsFiler reminds investors with losses over $100,000 to file by April 13, 2026 in case against Kyndryl Holdings, Inc.
Feb. 23, 2026
Investor Alert: Probe Launched into Kennedy-Wilson Proposed Sale
Kahn Swick & Foti, LLC investigating adequacy of price and process in $10.90 per share buyout offer.
Feb. 19, 2026
uniQure Faces Securities Fraud Class Action After FDA Approval Delay
Investors may contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC for more information
Feb. 16, 2026
Tri Pointe Homes Investor Alert: Probe Launched Into Proposed Sale
Kahn Swick & Foti, LLC investigating adequacy of price and process in Tri Pointe Homes sale to Sumitomo Forestry Co.
Feb. 14, 2026
Coupang Faces Lawsuits Over Data Breach
Kahn Swick & Foti, LLC Remind Investors of Deadline to Join Class Actions Against Coupang, Inc.
Feb. 10, 2026
Valaris Investor Alert: Kahn Swick & Foti Investigates Proposed Transocean Acquisition
Law firm examines if Valaris shareholders are being adequately compensated in the all-stock deal.
Feb. 9, 2026
Marine Products Investor Alert: Proposed Sale Investigated
Kahn Swick & Foti, LLC looking into adequacy of price and process in Marine Products Corporation sale to MasterCraft Boat Holdings.
Feb. 9, 2026
Valaris Investor Alert: Kahn Swick & Foti Investigates Proposed Transocean Acquisition
Law firm examines adequacy of price and process in potential Valaris sale
